Biotech Update: Provectus Biopharmaceuticals (OTCQB: PVCT)

| November 23, 2016

article image
SCN's Jane King sits down with CEO Peter Culpepper of Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) , to discuss the biopharmaceutical company and it's future outlook.

Spotlight

Mowlam Healthcare Services

Mowlam Healthcare, established in 2000, is one of the largest independent healthcare providers of quality nursing home care in Ireland. On any one day Mowlam Healthcare will assist and care for over 1,300 residents. We believe that a good and effective healthcare culture can only emerge out of professional and compassionate values – Mowlam values that benefit not only our residents and their families, but fundamentally guide the role we play in developing and creating quality home-from-home environments throughout Ireland.

OTHER ARTICLES

Clinical Supply Availability & Speed to Study Start-Up

Article | March 26, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

What to Watch in 2020: Non-Specialty Drugs

Article | March 1, 2020

Pharmaceutical manufacturers are constantly working to develop new and improved medications. Join us as we explore the non-specialty drugs you should be watching in 2020. If you missed last week’s article about the most important upcoming specialty drugs, be sure to check it out here. Approximately 40 new medications are approved by the Food and Drug Administration (FDA) every year.1 (Please note: If you’re curious about what it takes to develop a drug and bring it to market, check out our previous article). Why should you care about these new medications? Because they can affect both your organization’s pharmacy spend and your members’ cost share. For non-specialty drugs, we will focus on medications that may come to market this year, including ones that are currently being reviewed by the FDA, or that are in the last clinical trial (Phase III) stage.

Read More

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 4, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | February 11, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Spotlight

Mowlam Healthcare Services

Mowlam Healthcare, established in 2000, is one of the largest independent healthcare providers of quality nursing home care in Ireland. On any one day Mowlam Healthcare will assist and care for over 1,300 residents. We believe that a good and effective healthcare culture can only emerge out of professional and compassionate values – Mowlam values that benefit not only our residents and their families, but fundamentally guide the role we play in developing and creating quality home-from-home environments throughout Ireland.

Events